Condition
Arterial Occlusive Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Arterial Occlusive Diseases clinical trials that are recruiting, at sites in 7 countries (most in Spain (2), United States (2), Belgium (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 7Countries
Newest Arterial Occlusive Diseases clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease | — | Boston, Massachusetts and 14 other locations | Recruiting | Dec 16, 2025 |
| Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions | — | Washington D.C., District of Columbia and 2 other locations | Recruiting | Dec 2, 2025 |
| Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients | — | Milan, MI | Recruiting | Aug 2, 2024 |
| Using two stent retrievers at once versus one for treating acute ischemic stroke | — | Essen and 3 other locations | Recruiting | Jul 5, 2023 |
All recruiting trials (4)
-
Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease
This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
Using two stent retrievers at once versus one for treating acute ischemic stroke
We will test whether using two stent retrievers at the same time helps people with acute ischemic stroke get their blocked artery opened faster and recover better during mechanical thrombectomy.
Related topics
Quick answers
How many Arterial Occlusive Diseases clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Spain (2 trials), United States (2 trials), Belgium (1 trial), United Kingdom (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.